Helvetia Baloise Holding (HLVTY) Fair Value & Analysis
Financial Services · US · Market cap $30.3B
Fair value as of: Jun 26, 2026
From 23 valuation models · updated 13 days ago
Fair value updated Jun 26, 2026 — revised from $2.92 to $3.45 (+18.2%) since Jun 24, 2026. Share price +2.8% over the past month.
Price vs Fair Value (12 months)
12‑month range $3.91 – $7.46 · fair‑value band $2.59 – $4.31 · the $6.52 price screens above the $3.45 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Helvetia Baloise Holding (HLVTY) currently trades at $6.52, while our model-based Fair Value estimate is $3.45 — implying the stock looks roughly 47.1% overvalued today. We read business quality at 38/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Helvetia Baloise Holding generated revenue of $10.3B at a net margin of 5.4%. Revenue grew 17.9% year over year. It earns a return on equity of 6.3%. Net debt stands at $505M. Fundamentals as of Jun 26, 2026
Our scenario range runs from $2.59 (bear case) to $4.31 (bull case); at $6.52, the current price sits above that range. The share trades about 13% below its 52-week high and 67% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 18% fair-value upside — at -47%, HLVTY screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Helvetia Baloise Holding AG engages in life and non-life insurance, and reinsurance business. It offers life insurance products in the areas of investment-linked, group life, and traditional individual life others; non-life insurance products in the areas of property, motor vehicle, health/accident, liability, engineering, and transport; and pure risk, savings, endowment, and annuity insurance products, as well as pension plans and asset management services. The company also provides marine, aviation, and art insurance. It operates in Switzerland, Spain, Germany, Belgium, Luxembourg, Italian and Austrian Markets, France, and internationally The company was formerly known as Helvetia Holding AG and changed its name to Helvetia Baloise Holding AG in April 2022. Helvetia Baloise Holding AG was incorporated in 2017 and is headquartered in Basel, Switzerland.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Helvetia Baloise Holding reported revenue of $10.7B in FY2025 versus $12.0B in FY2021, a compound −3.0%/yr. Reported net income was $552M in FY2025, compounding +2.7%/yr from FY2021.
Is HLVTY fairly valued? → Check now
Similar stocks
10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Berkshire Hathaway Inc BRK | C$35.75 | C$32.35 | -10% |
| Allianz SE 1ALV | €420.00 | €397.72 | -5% |
| Zurich Insurance Group ZURVY | $36.15 | $29.58 | -18% |
| AXA SA 1CS | €44.03 | €67.43 | +53% |
| Assicurazioni Generali S.p.A ARZGY | $24.41 | $28.91 | +18% |
| Sun Life Financial Inc SLF | $77.50 | $61.89 | -20% |
| American International Group AIGB34 | R$386.46 | R$457.31 | +18% |
| The Hartford Insurance Group H1IG34 | R$727.00 | R$1,309 | +80% |
| Talanx AG TLLXY | $60.33 | $109.48 | +81% |
| Arch Capital Group ACGL | $91.31 | $179.69 | +97% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Helvetia Baloise Holding (HLVTY) undervalued?
What is the fair value of HLVTY?
What is the quality score of HLVTY?
What is the revenue of Helvetia Baloise Holding (HLVTY)?
What is the net profit margin of HLVTY?
Does Helvetia Baloise Holding pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
The 25 strongest value stocks, free every month
Enter your email to get the free monthly Top-25 report of the most undervalued quality stocks from 35,000+ analysed. Unsubscribe anytime.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.